Actio Biosciences Raises $66M Series B for Genetics-Driven Therapeutics
Financing co-led by Regeneron Ventures and Deerfield Management will support advancement of lead programs, ABS-1230 and ABS-0871 Phase 1 trial initiation expected in second half...